Your browser doesn't support javascript.
loading
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Di Blasi, Roberta; Le Gouill, Steven; Bachy, Emmanuel; Cartron, Guillaume; Beauvais, David; Le Bras, Fabien; Gros, François-Xavier; Choquet, Sylvain; Bories, Pierre; Feugier, Pierre; Casasnovas, Olivier; Bay, Jacques Olivier; Mohty, Mohamad; Joris, Magalie; Gastinne, Thomas; Sesques, Pierre; Tudesq, Jean-Jacques; Vercellino, Laetitia; Morschhauser, Franck; Gat, Elodie; Broussais, Florence; Houot, Roch; Thieblemont, Catherine.
Afiliación
  • Di Blasi R; University of Paris APHP, Saint-Louis Hospital, Hemato-oncology, DMU DHI, Paris, France.
  • Le Gouill S; Institut Curie, Paris, France.
  • Bachy E; HCL, Hematology, Lyon, France.
  • Cartron G; CHU Montpellier, Hematology department, UMR CRNS 5535, Montpellier, France.
  • Beauvais D; CHU de Lille, Hematology, Lille, France.
  • Le Bras F; APHP, CHU Créteil, Hematology, Creteil, France.
  • Gros FX; CHU de Bordeaux, Hematology, Bordeaux, France.
  • Choquet S; APHP, Hopital La Pitié Salpetrière, APHP, Hematology, Paris, France.
  • Bories P; Oncopole Toulouse, Hematology, Toulouse, France.
  • Feugier P; Centre Hospitalier Universitaire Nancy and INSERM 1256, Nancy, France.
  • Casasnovas O; CHU Dijon, Bourgogne, France.
  • Bay JO; CHU de Clermont-Ferrand, Hematology, Clermont-Ferrand, France.
  • Mohty M; APHP, Hopital Saint-Antoine, Sorbonne University, Paris, France.
  • Joris M; CHU Amiens, Hematology, Amiens, France.
  • Gastinne T; CHU Nantes, Hematology, Nantes, France.
  • Sesques P; HCL, Hematology, Lyon, France.
  • Tudesq JJ; CHU Montpellier, Hematology department, UMR CRNS 5535, Montpellier, France.
  • Vercellino L; Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis Service de médecine nucléaire, Paris, France.
  • Morschhauser F; CHU de Lille, Hematology, Lille, France.
  • Gat E; Institut Carnot CALYM, Lyon, France.
  • Broussais F; LYSARC CHU Lyon Pierre Bénite, Lyon, France.
  • Houot R; CHU Rennes, Rennes, France.
  • Thieblemont C; University of Paris APHP, Saint-Louis Hospital, Hemato-oncology, DMU DHI, Paris, France.
Blood ; 140(24): 2584-2593, 2022 12 15.
Article en En | MEDLINE | ID: mdl-36122385
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoterapia Adoptiva / Linfoma de Células B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Blood Año: 2022 Tipo del documento: Article País de afiliación: Francia